S&P Futures
3,825.50 0.00 (0.00%) Dow Futures
30,940.00 +7.00 (+0.02%) Nasdaq Futures
11,674.50 +0.25 (+0.00%) Russell 2000 Futures
1,738.00 -0.30 (-0.02%) Crude Oil
111.08 -0.68 (-0.61%) Gold
1,822.90 +1.70 (+0.09%)
Vera Therapeutics, Inc. (VERA)
After hours:
Chart Events
Performance Outlook
| Previous Close | 13.75 |
| Open | 13.92 |
| Bid | 5.31 x 3000 |
| Ask | 25.99 x 1000 |
| Day's Range | 13.02 - 13.92 |
| 52 Week Range | 12.28 - 37.11 |
| Volume | |
| Avg. Volume | 92,732 |
| Market Cap | 283.418M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.17 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.83 |
- Simply Wall St.
Insider Buying: The Vera Therapeutics, Inc. (NASDAQ:VERA) Chief Financial Officer Just Bought 329% More Shares
Whilst it may not be a huge deal, we thought it was good to see that the Vera Therapeutics, Inc. ( NASDAQ:VERA ) Chief...
- GlobeNewswire
Vera Therapeutics Reports Positive Interim Phase 2 Data Showing MAU868 Has Significant BK Antiviral Activity in Kidney Transplant Patients
MAU868, a first-in-class monoclonal antibody, was well tolerated in kidney transplant recipients with BK viremiaData presented as oral late breaker at American Transplant Congress BK Virus is a leading cause of transplant loss and transplant-associated morbidity; currently no approved treatments BRISBANE, Calif., June 04, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for pati
- GlobeNewswire
Vera Therapeutics to Participate in the 2022 Jefferies Healthcare Conference
BRISBANE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will present at the 2022 Jefferies Healthcare Conference, being held June 8-10, 2022 in New York, NY. The management team will also participate in one-on-one investor meetings. Presentation Details: Date:
